As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...
Morning Overview on MSN
AI foundation models trained on DNA could speed up plant research
A wave of AI foundation models built on plant DNA sequences is giving researchers new tools to annotate genomes, predict gene ...
Editor’s note: This is the first story in a two-part series on the use of foundation models in the medtech industry. The second story will be published on Tuesday. More medical device companies are ...
Much of the data we need to revolutionize drug discovery already exists. The problem is that, often, it isn’t usable. I spent years of my graduate research building algorithms that could sift through ...
Regtechtimes on MSN
Capital, compute, and conviction and how foundation model investing is reshaping the AI economy
Artificial intelligence is no longer an emerging category. It is infrastructure. In fact, the global private AI investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results